- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$158.7b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$102.00
7D
-4.2%
1Y
-25.3%
Bora Pharmaceuticals
Market Cap: NT$50.5b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$396.50
7D
1.0%
1Y
-43.0%
Lotus Pharmaceutical
Market Cap: NT$48.4b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$184.00
7D
-2.6%
1Y
-18.4%
Oneness Biotech
Market Cap: NT$22.2b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$46.25
7D
-3.2%
1Y
-28.6%
TaiMed Biologics
Market Cap: NT$16.1b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$58.90
7D
0%
1Y
-28.9%
Medigen Vaccine Biologics
Market Cap: NT$15.6b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$47.35
7D
0.7%
1Y
11.3%
EirGenix
Market Cap: NT$14.3b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$47.05
7D
4.8%
1Y
-28.5%
Foresee Pharmaceuticals
Market Cap: NT$12.9b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$81.60
7D
2.4%
1Y
10.4%